Renaissance Technologies - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 56 filers reported holding ETON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$350,385
+143500.4%
106,500
+63.8%
0.00%
Q1 2024$244
+30.5%
65,031
+52.3%
0.00%
Q4 2023$187
+3.9%
42,700
-1.2%
0.00%
Q3 2023$180
+87.5%
43,200
+56.5%
0.00%
Q2 2023$96
+84.6%
27,600
+106.0%
0.00%
Q1 2023$52
-100.0%
13,400
-63.1%
0.00%
Q1 2020$149,00036,2830.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 3,088,100$15,564,0002.91%
AWM Investment Company, Inc. 500,000$2,520,0000.25%
HighVista Strategies LLC 21,517$109,0000.07%
GSA CAPITAL PARTNERS LLP 82,314$415,0000.04%
XTX Topco Ltd 14,652$74,0000.02%
CHICAGO TRUST Co NA 16,700$84,0000.02%
Financial Advisors Network, Inc. 10,633$53,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,500$507,0000.01%
Westside Investment Management, Inc. 105,300$3,048,0000.01%
Belvedere Trading LLC 20,829$107,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders